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Abstract: 
 
A simple, sensitive, specific, spectrophotometric method developed for the detection of Risperidone in 
bulk drug and Pharmaceutical formulation. The optimum conditions for the analysis of the drug were 
established.  The λ max of the Risperidone was found to be 280 nm. The method shows high sensitivity with 
linearity 2 to 6µ g/ml. The lower limit of detection and the limit of quantification was found to be 1.012 and 
3.036 respectively. All the calibration curves shows a linear relationship between the absorbance and 
concentration and coefficient correlation was higher than 0.99. The regression of the curve was Y = 0.039x - 
0.002. Precision of the method was found to be 2.0325 ± 0.044 against the label claim of 2mg. The percentage 
recovery was found to be 102  0.188. The sample solution was stable up to 2 hours. The proposed method will 
be suitable for the analysis of RIS in bulk and pharmaceutical formulation. 
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Introduction: 
Risperidone (RIS) is belonging to the chemical class of Benzisoxazole derivatives and chemically It is 
4-(2-(4-(6-Flurobenzo[d]isoxazd-3yl]1-piperidyl] ethyl]-3-methyl-2,6 diazabicyclodeca-1,3-dien-5-one [1] with 
molecular formula C23 H27 FN4O2 was presented in fig 1. RIS is an antipsychotic agent [2], which acts through 
selective antagonism of serotonin 5HT2, dopamine D2
 receptors, used in the treatment of schizophrenia and other 
psychoses [3]. It is mostly metabolized by alicyclic hydroxylation and oxidative N- dealkylation [4]. An ideal 
stability indicating method is one that quantifies the drug and also resolves its degradation products [5]. RIS is 
soluble in 0.1N HCL and methanol and insoluble in sodium hydroxide and acetonitrile. The  max was found to 
be at 280nm.  
 
Fig 1: Structure of Risperidone 
  Literature review for RIS analysis revealed several methods based on different technique such as HPLC 
with UV detection [6].Visible spectrophotometric methods [7], LC-ms and HPLC ESI/MS assay for its 
quantification in plasma and serum [8-11],
  Chiral Chromatography [12], Pulse Polarography [13], 
Chemiluminescence assay [14], LC with coulometric Detection [15].  However there is no method reported for 
the detection of RIS in bulk and pharmaceutical formulation by UV spectrophotometry..  
The aim of present work is to find out a simple, sensitive, specific, spectrophotometric method 
developed for the detection of RIS in bulk drug and pharmaceutical formulation. 
 
Materials and Methods: 
Reagents & Materials 
RIS working standard was supplied by M/S Orchid chemicals and Pharmaceuticals, Chennai. RIS 
(Label claim: 2mg tablet) was manufactured by M/S Torrent Pharmaceutical Ltd Baddi, Solan (HP), India. All 
other chemicals used in the analysis were AR grade.   
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Apparatus 
A double – beam spectrophotometer Perkin Elmer (Lambda 25) was used for the detection of 
absorbance, Mettler Tremedo (weighing balance) and Bronson sonicator were used for experimental purpose.     
Method 
Preparation of stock solution 
100mg of the pure drug was weighed and transferred to a 100ml volumetric flask, 50ml 0.1N HCL was 
added to the above flask and dissolved, the volume was made up with the 0.1N HCL.   
Preparation of sample solution        
The average weight of the tablets were determined by weighing 10 tablets and these were powdered. 
Tablet powder equivalent to 2mg of RIS was weighed and transferred to a 100ml volumetric flask. About 20ml 
of 0.1N HCL was added and sonicated for 5 min for complete dissolution of drugs, the volume was made up 
with 0.1N HCL and mixed well, and then the above solution was filtered through Whatmann filter paper. 
Dilutions were made with 0.1N HCL to attain a concentration of 4g/ml. Six replicates of analysis were carried 
out with sample weighed individually. The average weight of tablet was found to be 0.21g. 
Method validation 
Various methods for analysis of RIS in bulk and pharmaceutical formulation was carried out as per 
ICH guideline.   
Linearity   
  The method was validated according to ICH Q2B guidelines [16] for validation of analytical 
procedures in order to determine the linearity, sensitivity, precision and accuracy of the analyte [17-22]. For 
RIS, five point calibration curves were generated with the appropriate volumes of the working standard 
solutions for UV methods. The linearity was evaluated by the least-square regression method using unweighted 
data. 
Precision and accuracy 
Precision is the degree of repeatability of an analytical method under normal operational conditions. 
The precision and accuracy were determined with standard quality control samples (in addition to calibration 
standards) prepared in triplicate at different concentration levels covering the entire linearity range. The 
precision of the assay was determined by repeatability (intraday) and intermediate precision (inter-day) and 
reported as RSD % for a statistically significant number of replicate measurements [16]. The intermediate 
precision was studied by comparing the assays on three different days and the results are documented as the 
standard deviation and RSD %. Accuracy is the percent of analyte recovered by assay from a known added 
amount. Data from nine determinations over three concentration levels covering the specified range were 
obtained. 
LOD and LOQ 
The limit of detection (LOD) is defined as the lowest concentration of an analyte that an analytical 
process can reliably differentiate from back-ground levels. In this study, LOD and LOQ were based on the 
standard deviation of the response and the slope of the corresponding curve using the following equations- 
LOD = 3 s/m; LOQ = 10 s/m 
  Where s, the noise of estimate, is the standard deviation of the absorbance of the sample and m is the 
slope of the related calibrations graphs. 
The limit of quantification (LOQ) is defined as the lowest concentration of the standard curve that 
can be measured with an acceptable accuracy, precision and variability [16-18]. The values of LOD and 
LOQ are given in Table 1. 
Table 1: Linearity study of RIS 
Concentration (g /ml)  Absorbance 
2 0.0799 
3 0.1101 
4 0.1519 
5 0.198 
6 0.232 
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Stability 
The stability of RIS in 0.1N HCL solution was studied by the UV method. Sample solutions were 
prepared in triplicate and stored at 4 and 25°C for 30, 60, 90 and 120min. The stability of these solutions was 
studied by performing the experiment.  
Recovery study 
Recovery of the analyte of interest from a given matrix can be used as a measure of the accuracy or the 
bias of the method. The same range of concentrations, as employed in the linearity studies, was used. To study 
the accuracy, precision and reproducibility of the proposed method and dosage forms, recovery experiments 
were carried out using the standard addition method. These studies were performed by the addition of known 
amounts of pure RIS to the pre-analyzed tablet formulation and the mixtures were analyzed using the proposed 
techniques. After parallel analyses, the recovery results were calculated using the related calibration equations. 
Results and Discussion: 
The development of a simple, rapid, sensitive and accurate analytical method for the routine 
quantitative determination of samples will reduce unnecessary tedious sample preparations and the cost of 
materials and labor. RIS is a UV-absorbing molecule with specific chromophores in the structure that absorb at 
a particular wavelength and this fact was successfully employed for their quantitative determinations using the 
UV spectrophotometric method. The max of the drug for analysis was determined by taking scans of the drug 
sample solutions in the entire UV region.It was found to be that only one peak was observed in this method at 
the wavelength of 240nm. 
Calibration curves 
Calibration curve data were constructed in the range of the expected concentrations of 2 g/mL to 6 
g/mL. Beer’s law was obeyed over this concentration range. The regression equation was found to be Y = 
0.039x - 0.002. The correlation coefficient (r) of the standard curve was found to be greater than 0.995. The 
stock solutions and working standards were made in 0.1N HCL. Calibration curve was presented in table 1 and 
fig 2. 
 
Fig 2: Calibration curve of RIS 
The analytical characteristics and necessary validation parameters for the UV techniques for RIS are 
presented in Table 2. 
Table 2: Validation parameters 
Parameters Values 
Linearity range (g/ml) 2-6 
Precision (%)  2.0325  0.044 
Accuracy (%)  102  0.188 
LOD (g/ml)  1.012 
LOQ (g/ml)  3.036 
Stability (h)  2 
Std Deviation (SD ±)  0.044 
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Performing replicate analyses of the standard solutions was used to assess the accuracy precision and 
reproducibility of the proposed methods. The selected concentration within the calibration range was prepared 
in 0.1N HCL and analyzed with the relevant calibration curves to determine the intra- and inter day variability. 
The intra- and inter day precision were determined as the RSD %. The precision, accuracy and reproducibility 
of the results are given in Tables 1, which demonstrate a good precision, accuracy and reproducibility. 
The proposed methods can be successfully applied for RIS assay in tablet dosage forms without any 
interference. The assay showed the drug content of this product to be in accordance with the labeled claim 2mg. 
The recovery of the analyte of interest from a given matrix can be used as a measure of the accuracy of the 
method. In order to check the accuracy and precision of the developed method and to prove the absence of 
interference by excipients, recovery studies were carried out after the addition of known amounts of the pure 
drug to various pre-analyzed formulations of all drugs. The application of this procedure is explained in the 
experimental section. The obtained results demonstrate the validity and accuracy of the proposed method for the 
determination of all drugs in tablets. These results reveal that the developed method have an adequate precision 
and accuracy and consequently, can be applied to the determination of RIS tablet in pharmaceuticals without 
any interference from the excipients. 
  The stability of RIS in 0.1N HCL solution was evaluated to verify whether any spontaneous 
degradation occurs, when the samples were prepared. The stability profile for 30, 60, 90 and 120min. the results 
were expressed as a percentage of the drug remaining. The obtained data showed that the sample solutions were 
stable during 2 h.  
Conclusion:  
The developed spectrophotometric method was simple, sensitive, and specific, for the detection of RIS 
in bulk & pharmaceutical formulation. It could be precisely quantify and LOD was found to be 1.012 and the 
limit of quantification to be 3.036. All the calibration curves shows a linear relationship between the absorbance 
and concentration and coefficient correlation was higher than 0.99. Precision of the method was found to be 
2.0325 ± 0.044 against the label claim of 2mg. The percentage recovery was found to be 102  0.188 and the 
sample solution was stable for up to 2 hours. The proposed method will be suitable for the analysis of RIS in 
bulk and pharmaceutical formulation. 
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